July 22, 2017 8:52 AM ET

Biotechnology

Company Overview of Ambit Biosciences Corporation

Key Executives for Ambit Biosciences Corporation

NameBoard RelationshipsTitleAge
Michael A. Martino 4 RelationshipsChief Executive Officer and President60
David J. Austin Ph.D.No RelationshipsCo-Founder, Chairman of Scientific Advisory Board--
Annette North Esq., LLBNo RelationshipsGeneral Counsel and Senior Vice President51

Ambit Biosciences Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
David Armistead Ph.D. 39 RelationshipsEnsemble Therapeutics Corporation--
Edward Roberts Ph.D., B.Sc 61 RelationshipsOncodesign Société Anonyme--
Webster K. Cavenee Ph.D. 33 RelationshipsLudwig Institute for Cancer Research Ltd.--
Tony Hunter Ph.D. 33 RelationshipsAmbit Biosciences Corporation--
Brian J. Druker M.D. 136 RelationshipsMolecularMD Corp.--
View All Board Members

Ambit Biosciences Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$440.1K
440.1K
389.6K
Bonus
Not meaningful
Total Short Term Compensation$440.1K
440.1K
483.9K
Total Value of Options
18.3M
Compensation as of Fiscal Year
Ambit Biosciences Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Valens GroWorks Corp. Appoints Saul Katz as President
July 21, 2017 4:19 AM ET
Aeterna Zentaris Inc. Announces Executive Changes
July 20, 2017 9:00 PM ET
Aeglea BioTherapeutics, Inc. Announces Executive Changes
July 20, 2017 8:01 PM ET
Trevena, Inc. Announces the Resignation of David Soergel as Chief Medical Officer
July 20, 2017 7:33 PM ET
Nivalis Therapeutics, Inc. Announces Executive Changes
July 20, 2017 11:03 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ambit Biosciences Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.